Guangdong Jiaying Pharmaceutical Co., Ltd. (002198) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Guangdong Jiaying Pharmaceutical Co., Ltd.

Why is Guangdong Jiaying Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 6.47%

The company has been able to generate a Return on Capital Employed (avg) of 6.47% signifying low profitability per unit of total capital (equity and debt)

Flat results in Mar 25

INTEREST(HY) At CNY 0 MM has Grown at 788.09%
NET SALES(9M) At CNY 311.71 MM has Grown at -14.33%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.86%

With ROE of 4.95%, it has a expensive valuation with a 3.98 Price to Book Value

Over the past year, while the stock has generated a return of -2.03%, its profits have risen by 67.8% ; the PEG ratio of the company is 1.2

Below par performance in long term as well as near term

Along with generating -2.03% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Guangdong Jiaying Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Guangdong Jiaying Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Guangdong Jiaying Pharmaceutical Co., Ltd.

-12.05%

-0.05

34.52%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.37%

EBIT Growth (5y)

54.66%

EBIT to Interest (avg)

26.49

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.37

Sales to Capital Employed (avg)

0.66

Tax Ratio

17.93%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

6.47%

ROE (avg)

3.75%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.98

EV to EBIT

64.83

EV to EBITDA

42.54

EV to Capital Employed

5.12

EV to Sales

6.85

PEG Ratio

1.19

Dividend Yield

ROCE (Latest)

7.89%

ROE (Latest)

4.95%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 19.84 MM has Grown at 174.97%

NET PROFIT(Q)

At CNY 15.8 MM has Grown at 204.91%

RAW MATERIAL COST(Y)

Fallen by -30.75% (YoY

NET SALES(Q)

Highest at CNY 119.67 MM

-14What is not working for the Company

INTEREST(HY)

At CNY 0 MM has Grown at 788.09%

NET SALES(9M)

At CNY 311.71 MM has Grown at -14.33%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.86%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.45%

Here's what is working for Guangdong Jiaying Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 19.84 MM has Grown at 174.97%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 15.8 MM has Grown at 204.91%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

Highest at CNY 119.67 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 119.67 MM has Grown at 29.07%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost

Fallen by -30.75% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Guangdong Jiaying Pharmaceutical Co., Ltd.

Interest

At CNY 0 MM has Grown at 788.09%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 1.86% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.45%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio